Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.
about
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesSui generis: gene therapy and delivery systems for the treatment of glioblastomaOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyTrial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyUnlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyDesigning Herpes Viruses as Oncolytics.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMASingle agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaTargeting tumor vasculature through oncolytic virotherapy: recent advances.Cancer subclonal genetic architecture as a key to personalized medicine.Clinical trials of viral therapy for malignant gliomas.Evolution of oncolytic viruses: novel strategies for cancer treatment.Oncolytic viral therapy: targeting cancer stem cellsBlockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Oncolytic Immunotherapy for Treatment of Cancer.Immune and viral therapies for malignant primary brain tumors.Evaluation of JC and Cytomegalo Viruses in Glioblastoma TissueGene Delivery in Neuro-Oncology.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.Immunovirotherapy for the treatment of glioblastoma.Immunovirotherapy for glioblastoma.Panorama from the oncolytic virotherapy summit.Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
P2860
Q26767212-13842138-8380-4100-94F0-4DD2FFE14948Q26850467-E68BB7F2-400D-4237-A7BE-DCCCD9A9BDFFQ26998111-9CDD8277-D19C-460C-B82B-E254C5A68C5EQ27021951-1D85CBD0-ED07-475E-8D3D-1B267E63C5B0Q28072347-87A32695-9922-4B98-AD00-09F496661FDEQ35657822-874B85B1-4108-4E58-9612-88FC8694C6A4Q36142487-D1CCC2AC-D1D0-44B1-96DA-D156CB230EA8Q36549443-39E47554-FA73-4465-AFDD-DAD3ADDAB567Q36575238-4A4BB9F3-6994-4703-ABE8-D875B4CD202DQ37031932-665A9374-3AC8-411D-9FD1-4183C7C513C3Q37448116-46B27D7C-0773-4FF1-9EB5-789C3352CD28Q38153777-7A8BA1FF-424C-4482-A169-BA1B24EDAEF7Q38159802-17D08B2C-A45E-41A8-BDE2-04116A99BBC4Q38212255-8A616A94-D41E-4024-8AEE-E91031AFA68DQ38400073-8A10415D-FE0F-417F-AC11-842CC03FD0E3Q38657642-385EA61F-CE0A-451E-B57A-2A3A54DD09E3Q38727470-0B406786-FA7B-4481-A392-C62B50FFBEC3Q38848223-9C32E80E-58C9-496A-ACE1-CB31B4B32A64Q39168899-4107459D-8AFD-4061-90BA-A3D0404BBFAEQ39207811-5AA7690E-1E7A-46C6-91E6-07282C2B7DE4Q40060078-A671AA86-3267-4469-868C-01123D3B8572Q40178043-F18C5B2A-DB72-477A-A5EF-0228AFFF631FQ41966303-F867ED39-8275-4AC7-A962-10FC36768CB0Q42725119-19206896-7F24-43BA-B14F-0D04720E9C42Q42934744-B57E3FF1-D278-4E5B-8A4B-279C892549C8Q48483233-7E698D5E-E339-4339-9801-8A2610383270Q52337612-3D3C5BE9-0D68-49C2-9C38-AE1D7E0E5C8FQ52715248-08BE63D5-2245-4F51-8FA2-AF728C2A523DQ55075584-67EA43C5-56DA-49F0-BF54-0E2FD45D3B7DQ56378150-E6CA8A2C-4E4E-443F-A27B-9D97750A9C98
P2860
Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Combination of oncolytic herpe ...... in human glioblastoma models.
@en
type
label
Combination of oncolytic herpe ...... in human glioblastoma models.
@en
prefLabel
Combination of oncolytic herpe ...... in human glioblastoma models.
@en
P2093
P2860
P50
P356
P1433
P1476
Combination of oncolytic herpe ...... y in human glioblastoma models
@en
P2093
Anat O Stemmer Rachamimov
Giulia Fulci
Hiroaki Wakimoto
Jason S Buhrman
Tooba A Cheema
P2860
P304
P356
10.1593/NEO.13158
P577
2013-06-01T00:00:00Z